Gene interactions and pathways from curated databases and text-mining

◀ Back to ESR2

BRCA1 — ESR2

Text-mined interactions from Literome

Hilakivi-Clarke et al., Cancer Res 2000 (Breast Neoplasms...) : Findings obtained in in vitro assays and animal studies indicate that estrogens might influence the activity of the tumor suppressor gene BRCA1, and BRCA1 in turn may suppress the activity of the estrogen receptor
Fan et al., Oncogene 2001 (Breast Neoplasms) : Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
Zheng et al., Proc Natl Acad Sci U S A 2001 (Adenocarcinoma...) : BRCA1 mediates ligand independent transcriptional repression of the estrogen receptor
Fan et al., Cancer Res 2002 (Breast Neoplasms...) : p300 Modulates the BRCA1 inhibition of estrogen receptor activity ... We previously reported that expression of the breast cancer susceptibility gene BRCA1 strongly inhibits the transcriptional activity of the estrogen receptor ( ER-alpha ) in human breast and prostate cancer cell lines but only weakly inhibits ER-alpha activity in cervical cancer cells ( S. Fan et al., Science ( Wash. DC ), 284 : 1354-1356, 1999 )
Ma et al., Mol Endocrinol 2006 : Previously, the breast cancer susceptibility gene product BRCA1 was found to interact with and inhibit the transcriptional activity of estrogen receptor-alpha ... Whereas down-regulation of the coactivator p300 contributes to the BRCA1 mediated repression of estrogen receptor-alpha , this mechanism does not contribute to inhibition of PR activity, because exogenous p300 did not rescue the BRCA1 repression of PR activity
Thasni et al., Eur J Pharmacol 2008 (Ovarian Neoplasms) : Genistein inhibits estrogen receptor-alpha and activates BARD1 in BRCA1 blocked cells and induces estrogen receptor-beta and FAS in presence of BRCA1
Burga et al., Breast Cancer Res 2011 (Cell Transformation, Neoplastic...) : Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor negative cancers in BRCA1-mutant mice